Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-01-09
2007-01-09
Tsang, Cecilia J. (Department: 1654)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S013300, C514S041000, C514S042000, C514S062000
Reexamination Certificate
active
10831224
ABSTRACT:
Novel amino-modified polysaccharides are provided. The amino-modified polysaccharides have one or more amino groups, each being linked to one or more arginine residues.
REFERENCES:
patent: 2005/0085432 (2005-04-01), Lapidot
Aboul-Ela et al, “The structure of the human immunodeficiency virus type-I TAR RNA reveals principles of RNA recognition by Tat protein”,J MOl Biol.Oct. 20, 1995;253(2):313-32.
Appelt k, “Crystal structures of HIV-1 protease-inhibitor complexes”,Pers in Drug Disc&Design,, 1:23-48, 1993.
Baldwin et al, “Inhibiting HIV-1 entry with fusion inhibitors”,Curr Med Chem. Sep. 2003;10(17):1633-42.
Bartel et al, “HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA”,Cell.Nov. 1, 1991;6793):529-36.
Battiste et al, “Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex”,Science. Sep. 13, 1996;2763(5281):1547-51.
Berger et al, “Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease”,Annu Rev Immunol. 1999;17:657-700.
Borkow et al, “Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase”,J Virol. Apr. 1997;71(4):3023-30.
Borkow et al, “Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate”,Biochem Biophys Res Commun. Dec. 26, 2003;312(4):1047-52.
Borkow et al, “Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step”,Antiviral Res. Nov. 2003;60(3):181-92.
Bradshaw et al, “Preparation of diamino ethers and polyamines”,Tetrahedron, 48(22:4475-4515, 1992.
Le Bris, “One Pot Symentrical and Dissymentrical Regiospecific ω, ω1-Bis Mono N-Alkylation of Linear Tetraamines via their Chromium, Molybdneum or Tungsten Tricarbonyl Complexes”, Tetrahedron Letters, 34(34):5429-5432, 1993.
Brodsky rt al, “Solution structure of the HIV-2 TAR-argininamide complex”,J Mol Biol. Apr. 4, 1997;267(3):624-39.
Cabrera et al, “Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection”,AIDS Res Hum Retroviruses. May 1, 2000;16(7):627-34.
Cabrera et al, “Anti-HIV activity of a novel aminoglycoside-arginine conjugate”,Antiviral Res. Jan. 2002;53(1):1-8.
Calnan et al, “Arginine-mediated RNA recognition: the arginine fork”,Science. May 24, 1991;252(5010):1167-71. Erratum in: Science Feb. 7, 1992;255(5045):665.
Carriere et al, “Inhibition of protein synthesis by aminoglycoside-arginine conjugates”,RNA. Oct. 2000;8(10);1267-79.
Catani et al, “The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells”,J Neurochem. Mar. 2003;84(6):1237-45.
Chackerian et al, “Human immunodeficiency virus type 1 corecpetors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection”,J Virol. May 1997;71(5):3932-9.
Chan et al, “Core structure of gp41 from the HIV envelope glycoprotein”, Cell. Apr. 18, 1997;89(2):263-73.
Chapman et al, “Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening”,Antiviral Res. Jun. 2002;54(3):149-62.
Chatterjee et al, “Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector”,Science. Nov. 27, 1992;258(5087):1485-8.
Cheng et al, “Design of RNA-binding proteins and ligands”,Curr Opin Struct Biol. Aug. 2001;11(4):478-84.
Choe et al, “Structural interactions between chemokine receptors, gp120 Env and CD4”,Semin Immunol. Jun. 1998;10(3):249-57.
Clapham et al, “HIV-1 receptoras and cell tropism”,Br Med Bull. 2001;58:43-59.
Collins et al, “Development of an in vitro organ model to study transmission of HIV-1 in the female gential tract”,Nat Med. Apr. 2000;6(4):475-9.
De Clercq, E., “New anti-HIV agents and targets”,Med Res Rev. Nov. 2002;22(6):531-65.
De Vreese et al, “The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication”,J Virol. Feb. 1996;70(2):689-96.
Delling et al, “The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA”,Proc Natl Acad Sci U S A. Jul. 15, 1991;88(14):6234-8.
Erikson, JW, “Design and structure of symmetry-based inhibitors of HIV-1 protease”,Perspective in Drug Discovery and Design, 1:109-128, 1993.
Enninfar et al, “HIV-1 RNA dimerization initiation site is structurally similar to the ribosmal A site and binds aminoglycoside antibiotics”,J Biol Chem. Jan. 24, 2003;278(4):2723-30. Epub Nov. 14, 2002.
Este, JA, “Virus entry as a target for anti-HIV intervention”,Curr Med Chem. Sep. 2003;10(17):1617-32.
Eubank et al, “Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates”FEBS Lett. Jan. 30, 2002;511(1-3):107-12.
Fourmy et al, “Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA”,J Mol Biol. Mar. 27, 1998;277(2):347-62.
Gohlke et al, “Statistical potentials and scoring functions applied to protein0ligand binding”,Curr Opin Struct Biol. Apr. 2001;11(2):231-5.
Gosser et al, “Peptide-triggered conformational switch in HIV-1 RRE RNA complexes”,Nat Struct Biol. Feb. 2001;8(2):146-50.
Halperin et al, “Principles of docking: An overview of search algorithms and a guide to scoring functions”,Proteins. Jun. 1, 2002;47(4):409-43.
Hamasaki et al, “Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators”,Bioorg Med Chem Lett. Feb. 26, 2001;11(4):591-4.
Hung et al, “The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability”,Proc Natl Acad Sci U S A. May 9, 2000;97(10):5107-12.
Ippolito et al, “The structure of the HIV-1 RRE high affinity rev binding site at 1.6 A resolution”,J Mol Biol. Jan. 28, 2000;295(4):711-7.
Kjems et al, “Specific binding of a basic peptide from HIV-1 Rev”,EMBO J. Mar. 1992;11(3):1119-29.
Krakowiak et al, “Selective Protection of the Primary Amine Functions of Linear Teraamines Usinf the Trityl Group”,Synthetic Comm., 28(18):3451-3459, 1998.
Lacourciere et al, “Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy”,Biochemistry. May 16, 2000;39(19):5630-41.
Lam et al, “Rational design of potent, bioavailable , nonpeptide cyclic ureas as HIV protease inhibitors”,Science. Jan. 21, 1994;263(5145):380-4.
Lapidot et al, “Novel HIV Tat antagonists”,Drug Development Research50:502-515, 2000.
Litovchick et al, “Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity”,Biochemistry. Mar. 21, 2000;39(11)2838-52.
Litovchick et al, “Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities”,Biochemistry. Dec. 25, 2001;40(51):15612-23.
Litovchick et al, “Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro”,FEBS Lett. Feb 19, 1999;445(1):73-9.
Long et al, “Charcterization of the solution conformations of unbound and Tat peptide-bound forms of IV-1 TAR RNA”,Biochemistry. Aug. 3, 1999;38(31):10059-69.
Lu et al, “Detritylation with ytterbium triflate”,Tetrahedron Lett., 41:2817-2819, 2000.
Ma et al, &#
Borkow Gadi
Lapidot Aviva
Vijayabaskar Veerappan
Kosar Andrew D.
Tsang Cecilia J.
Yeda Research and Development Co. Ltd.
LandOfFree
Amino-modified polysaccharides and methods of generating and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-modified polysaccharides and methods of generating and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-modified polysaccharides and methods of generating and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767122